The analysis of large genetic datasets indicates the existence of an association between TP53 mutational status in breast cancer and the presence of infiltrating immune cells; particularly, the mutation of TP53 R175H was associated with increased immune infiltration [324]. The gene discussed is TP53; the disease is breast carcinoma.